Can provide either a newly obtained or archival tumor tissue sample. ECOG 0-1. Life expectancy of greater than 12 weeks. Adequate organ function. Female: child bearing potential, a negative urine or serum pregnancy test result within 72 h before study treatment. Participants of reproductive potential must be willing to use adequate contraception for the course of the study through 3 months after the last dose of SHR-1210.